A Leading Health Insurance Company Engaged Stax to Assess the Opportunity for a New Business Within Several Target Markets

A Leading Health Insurance Company Engaged Stax to Assess the Opportunity for a New Business Within Several Target Markets

February 11, 2019
February 11, 2019

Share

THE SITUATION

  • The client seeks national expansion, planning to launch a new business, offering self funded plans for small group employers within several target markets.
  • Stax assignment: Determine addressable market size and assess the competitive landscape within the target geographies.

THE ASSIGNMENT

  • We conducted a comprehensive assessment of the target markets, the landscape and channel dynamics, determining current and potential market opportunity.

THE BENEFITS

  • Based on our assessment we were able to provide a market map of the commercial payer landscape in each target market, including: Size, Share and expected shifts in share.
  • Stax was able to provide a comparison and review of offerings and key competitors in the space for prioritization of most attractive markets for growth expansion.

THE FINDING

  • Growing Acceptance of Self-Funding:
  • There is growing awareness and interest in self-funding among smaller employers. More brokers are presenting self-funding as an option to smaller employers—sometimes to firms as small as 5–10 employees.
  • Broker’s Play a Large Role in Employer Benefits Decision-Making:
  • Benefits decision-makers in small-mid sized firms lack familiarity with both the extent and variety of available plan options as well as current regulations and their implications. Therefore, smaller employers tend to rely heavily on brokers to recommend the plans best-suited for them—entrusting them to understand their needs and shop for plans.
  • High Healthcare Costs is a Key Pain Point:
  • Driving down healthcare costs is a key concern for smaller employers as premiums and employer contributions continue to rise at 4%–5% annually over the last 5 years. Greater cost predictability and sustainable financial management are particularly critical for smaller employers in the current healthcare environment.

Read More

Grant Thornton Stax Advises Thoma Bravo on Merger of Hypergene & Stratsys
December 19, 2025
Grant Thornton Stax recently supported Hypergene, a portfolio management solutions backed by Thoma Bravo, on its recent merger with Stratsys. Read about the deal here.
Grant Thornton Stax Community ERG Unites to Give Back
December 17, 2025
Our teams across the US offered to spread some holiday cheer, rallying together to donate toys to local charities. Read about our various efforts, as well as charities you can donate to.
Grant Thornton Stax Sell-side: Pairsoft Investment by TA Assoc.
December 17, 2025
Grant Thornton Stax supported Pairsoft, a leading provider of procure-to-pay automation and payment solutions, on its recent majority growth investment by TA Associates. Read more.
Grant Thornton Stax Sell-side Support: Moss Acquisition by Vomela
December 17, 2025
Grant Thornton Stax recently supported Moss, a global producer of innovative brand experiences, on its acquisition by Vomela, a Riverside Company. Read more about the deal here.
Will Barden Named Among The Consulting Report’s Top 25 Strategy Leaders of 2025
By Will Barden December 11, 2025
Will Barden, Partner, has been named among "The Consulting Report's" Top 25 Strategy Leaders of 2025. Click here to read more about the award.
Investing in Pharma Technology: A Healthcare Breakfast Discussion
By Rob Larson & Jordan Abrams December 8, 2025
In partnership with Raymond James and Farragut Square Group, Grant Thornton Stax recently hosted a breakfast event to share our investment analysis of the Pharma Technology market.
Show More